NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MPLX LP (NYSE:MPLX), TESARO, Inc. (NASDAQ:TSRO), LKQ Corporation (NASDAQ:LKQ), Cytokinetics, Incorporated (NASDAQ:CYTK), Keysight Technologies Inc. (NYSE:KEYS), and Charles River Laboratories International, Inc. (NYSE:CRL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
MPLX DOWNLOAD: http://Fundamental-Markets.com/register/?so=MPLX
TSRO DOWNLOAD: http://Fundamental-Markets.com/register/?so=TSRO
LKQ DOWNLOAD: http://Fundamental-Markets.com/register/?so=LKQ
CYTK DOWNLOAD: http://Fundamental-Markets.com/register/?so=CYTK
KEYS DOWNLOAD: http://Fundamental-Markets.com/register/?so=KEYS
CRL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CRL
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine MPLX LP (NYSE:MPLX), TESARO, Inc. (NASDAQ:TSRO), LKQ Corporation (NASDAQ:LKQ), Cytokinetics, Incorporated (NASDAQ:CYTK), Keysight Technologies Inc. (NYSE:KEYS), and Charles River Laboratories International, Inc. (NYSE:CRL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed April 18th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
MPLX LP (MPLX) REPORT OVERVIEW
MPLX LP's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, MPLX LP reported revenue of $1,085.00MM vs $848.00MM (up 27.95%) and basic earnings per share $0.32 vs $0.22 (up 45.45%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MPLX LP reported revenue of $3,867.00MM vs $3,029.00MM (up 27.67%) and basic earnings per share $1.07 vs $0.00. MPLX LP is expected to report earnings on May 1st, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $2.11 and is expected to report on February 7th, 2019.
To read the full MPLX LP (MPLX) report, download it here: http://Fundamental-Markets.com/register/?so=MPLX
-----------------------------------------
TESARO, INC. (TSRO) REPORT OVERVIEW
TESARO's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, TESARO reported revenue of $48.02MM vs $4.92MM (up 875.88%) and basic earnings per share -$3.33 vs -$2.62. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TESARO reported revenue of $223.33MM vs $58.02MM (up 284.93%) and basic earnings per share -$9.17 vs -$7.85. TESARO is expected to report earnings on May 8th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$2.55. The estimated EPS forecast for the next fiscal year is -$6.34 and is expected to report on February 26th, 2019.
To read the full TESARO, Inc. (TSRO) report, download it here: http://Fundamental-Markets.com/register/?so=TSRO
-----------------------------------------
LKQ CORPORATION (LKQ) REPORT OVERVIEW
LKQ's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, LKQ reported revenue of $2,469.86MM vs $2,150.41MM (up 14.86%) and basic earnings per share $0.40 vs $0.27 (up 48.15%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, LKQ reported revenue of $9,736.91MM vs $8,584.03MM (up 13.43%) and basic earnings per share $1.73 vs $1.51 (up 14.57%). LKQ is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.49. The estimated EPS forecast for the next fiscal year is $2.58 and is expected to report on February 28th, 2019.
To read the full LKQ Corporation (LKQ) report, download it here: http://Fundamental-Markets.com/register/?so=LKQ
-----------------------------------------
CYTOKINETICS, INCORPORATED (CYTK) REPORT OVERVIEW
Cytokinetics' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Cytokinetics reported revenue of -$0.02MM vs $33.14MM and basic earnings per share -$0.77 vs $0.17. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cytokinetics reported revenue of $13.37MM vs $106.41MM (down 87.44%) and basic earnings per share -$2.59 vs $0.41. Cytokinetics is expected to report earnings on April 26th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was -$0.62. The estimated EPS forecast for the next fiscal year is -$1.92 and is expected to report on February 21st, 2019.
To read the full Cytokinetics, Incorporated (CYTK) report, download it here: http://Fundamental-Markets.com/register/?so=CYTK
-----------------------------------------
KEYSIGHT TECHNOLOGIES INC. (KEYS) REPORT OVERVIEW
Keysight Technologies' Recent Financial Performance
For the three months ended January 31st, 2018 vs January 31st, 2017, Keysight Technologies reported revenue of $837.00MM vs $726.00MM (up 15.29%) and basic earnings per share $0.50 vs $0.64 (down 21.88%). For the twelve months ended October 31st, 2017 vs October 31st, 2016, Keysight Technologies reported revenue of $3,189.00MM vs $2,918.00MM (up 9.29%) and basic earnings per share $0.57 vs $1.97 (down 71.07%). Keysight Technologies is expected to report earnings on June 5th, 2018. The report will be for the fiscal period ending April 30th, 2018. The reported EPS for the same quarter last year was $0.59.
To read the full Keysight Technologies Inc. (KEYS) report, download it here: http://Fundamental-Markets.com/register/?so=KEYS
-----------------------------------------
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) REPORT OVERVIEW
Charles River Laboratories International's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Charles River Laboratories International reported revenue of $478.48MM vs $466.79MM (up 2.50%) and basic earnings per share -$0.62 vs $0.94. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Charles River Laboratories International reported revenue of $1,857.60MM vs $1,681.43MM (up 10.48%) and basic earnings per share $2.60 vs $3.29 (down 20.97%). Charles River Laboratories International is expected to report earnings on May 10th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $1.29. The estimated EPS forecast for the next fiscal year is $6.58 and is expected to report on February 12th, 2019.
To read the full Charles River Laboratories International, Inc. (CRL) report, download it here: http://Fundamental-Markets.com/register/?so=CRL
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Canjex Publishing Ltd. All rights reserved.